| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009612589 |
| P356 | DOI | 10.1007/S10096-008-0605-4 |
| P698 | PubMed publication ID | 18758832 |
| P2093 | author name string | S Leonardi | |
| M La Rosa | |||
| G Vitaliti | |||
| L Spicuzza | |||
| C Sciuto | |||
| G Di Dio | |||
| P2860 | cites work | Microbiology of airway disease in a cohort of patients with cystic fibrosis | Q25256069 |
| Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status | Q33973155 | ||
| Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis | Q34686580 | ||
| Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. | Q35536317 | ||
| Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 | ||
| Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. | Q39466111 | ||
| Microbiology of sputum from patients at cystic fibrosis centers in the United States | Q44982403 | ||
| Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. | Q45089011 | ||
| Alcaligenes infection in cystic fibrosis. | Q51711085 | ||
| Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study | Q59139143 | ||
| The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain | Q64450132 | ||
| Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis | Q73912840 | ||
| Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence | Q74683395 | ||
| P433 | issue | 2 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 191-195 | |
| P577 | publication date | 2008-08-29 | |
| P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
| P1476 | title | Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients | |
| P478 | volume | 28 |
| Q33769610 | Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients |
| Q35658468 | Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human Pathogens |
| Q55362858 | Aspergillus fumigatus Inhibits Pseudomonas aeruginosa in Co-culture: Implications of a Mutually Antagonistic Relationship on Virulence and Inflammation in the CF Airway. |
| Q35918209 | Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections |
| Q47097212 | Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis |
| Q37812469 | Challenging and emerging pathogens in cystic fibrosis |
| Q40704655 | Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis |
| Q92901904 | Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study |
| Q60917956 | Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry |
| Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
| Q33592546 | Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. |
| Q33410138 | Community-acquired Stenotrophomonas maltophilia infections: a systematic review |
| Q40964077 | Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm. |
| Q36061478 | Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature |
| Q42381089 | Epidemiology and outcomes of Stenotrophomonas maltophilia and Burkholderia cepacia infections among trauma patients of India: a five year experience |
| Q42727109 | In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia |
| Q90196597 | Loci Encoding Compounds Potentially Active against Drug-Resistant Pathogens amidst a Decreasing Pool of Novel Antibiotics |
| Q33526875 | Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method |
| Q33697276 | Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy |
| Q37695294 | Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains |
| Q53699194 | Overexpression of the efflux pumps SmeVWX and SmeDEF is a major cause of resistance to cotrimoxazole in Stenotrophomonas maltophilia. |
| Q39606842 | Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. |
| Q36980425 | Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers |
| Q33877139 | Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis |
| Q42376062 | Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions |
| Q35199103 | Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degrees |
| Q27670726 | The Binding of Triclosan to SmeT, the Repressor of the Multidrug Efflux Pump SmeDEF, Induces Antibiotic Resistance in Stenotrophomonas maltophilia |
Search more.